Pay in 4 interest-free payments of $5.97 Learn more
Ships within 48 hours · Estimated delivery Sep 29 - Oct 4
Key Facts About Retatrutide 30mg Compound: Retatrutide Research identifier: LY3437943 Research class: Triple receptor agonist model Pathways studied: GLP-1, GIP, and glucagon receptor pathways Common search terms: GLP-3, GLP-R, triple agonist peptide, next-generation GLP-1 research compound Format: Lyophilized research peptide Use: Laboratory research only Retatrutide 30mg Research Compound Overview Retatrutide 30mg is a high-purity, batch-verified research peptide supplied for laboratories requiring consistency, analytical precision, traceability, and controlled sourcing
Since many GLP-1 drugs were approved to treat diabetes, health insurance companies wont approve their use without an A1C of 6.5%
in 2- 3 weeks
The explosion of GLP-1 medications like Ozempic, Wegovy, and Mounjaro has created something unprecedented in weight management
US$ 27.92
US$ 28.51
US$ 24.87
US$ 28.33
.jpg)
US$ 23.66
US$ 28.78
US$ 28.53
US$ 28.53
